Research has examined how glucagon receptor activation contributes to energy expenditure, hepatic lipid metabolism, and thermogenesis and crucially, how these effects interact with simultaneous GLP-1R and GIPR activation, a research question unique to tri-agonist compounds
These three principles preserve the peptide and protect your investment
Any unused portion should be discarded after admixture with a drug or solution to maintain sterility
Baseline and interval laboratory monitoring should include: fasting glucose and HbA1c (tirzepatide can cause hypoglycemia in non-diabetic subjects if caloric intake drops too low), lipase and amylase (pancreatitis risk with GLP-1 agonists), liver function tests (AST, ALT, bilirubin), and thyroid panel (TSH, free T3, free T4)